Koyfin Home > Directory > Health Care > Inovio Pharma > Total Equity

Inovio Pharma Total Equity Chart (INO)

Inovio Pharma annual/quarterly Total Equity from 2010 to 2020.
  • Inovio Pharma Total Equity for the quarter ending June 06, 2020 was $186m a 80.62% increase of 150m year over year
  • Inovio Pharma Total Equity for the last 12 months ending June 06, 2020 was $186m a 80.62% increase of 150m year over year
  • Inovio Pharma Annual Total Equity for 2019 was $5m a -1,510.26% decrease of -82m from 2018
  • Inovio Pharma Annual Total Equity for 2018 was $87m a -63.72% decrease of -55m from 2017
  • Inovio Pharma Annual Total Equity for 2017 was $142m a 13.41% increase of 19m from 2016
Other Balance Sheet Metrics:
  • Inovio Pharma Total Assets for the quarter ending September 09, 2018 was $141m a -33.08% decrease of -47m year over year
  • Inovio Pharma Other Liabilities for the quarter ending December 12, 2018 was $9m a -4.71% decrease of 0m year over year
View Chart On Koyfin

Quarterly INO Total Equity Data

06/2020$186m
03/2020$188m
12/2019$5m
09/2019$36m
06/2019$56m
03/2019$81m
12/2018$87m
09/2018$104m
06/2018$111m
03/2018$113m

Annual INO Total Equity Data

2019$5m
2018$87m
2017$142m
2016$123m
2015$176m
2014$112m
2013$53m
2012$35m
2011$48m
2010$47m